WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 11'266  11'271  11'276  11'282  11'289  11'138  10'601  9'835 
Births 107  108  110  112  114  145  177  159 
Surviving infants 107  108  109  111  114  144  175  156 
Pop. less than 5 years 529  532  545  570  592  731  898  803 
Pop. less than 15 years 1'827  1'862  1'902  1'953  1'998  2'411  2'457  3'116 
Female 15-49 years 2'863  2'915  2'958  2'988  3'013  3'024  2'946  2'433 

Number of reported case

(Click for retrospective incidence data for Cuba)
Diphtheria
Japanese encephalitis
Measles 12  3'924 
Mumps
Pertussis 70  131 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 26 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Cuba)
Vaccine year result method % card seen                                                
BCG 2009  100  MICS   95  100  100  99  99  99  99  98  99 
DTP1 2009  99  MICS   95  95  99*  99*  96  99*  93 
DTP3 2009  97  MICS   95  96  99*  99*  96  96  95  92  67 
HepB_BD          100  99  99  99  99  99 
HepB3 2009  97  MICS   95  96  99*  99*  96  96  98 
Hib3 2009  97  MICS   95  96  99*  99*  96  96  78 
JapEnc         
MCV 2009  97  MICS   95  99*  99*  99*  99*  99*  94  94  48 
MCV2          99*  99*  95  98  95 
PCV1         
PCV3         
Pol3          98  98  100  100  100  99  94  99 
Rota1         
Rota_last         
Rubella1          99*  99*  99*  99*  99* 
TT2plus          17  71  55  77  74 
PAB         
VAD1         
YFV          100  100 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Cuba)
BCG 99  99  99  99  99  99  98  99 
DTP1 98  98  96  96  98  98  97  86 
DTP3 96  96  96  96  96  95  92  67 
HepB3 96  96  96  96  96  98 
HepB_BD 99  99  99  99  99  99 
Hib3 96  96  96  96  96  99 
MCV 99  99  99  99  99  94  94  48 
MCV2 95  95  95  98  95 
PCV3
Pol3 98  98  99  99  99  98  94  99 
Rota_last

Number of districts in the country 168  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 93
From 80 to 89% 3
From 50 to 79% 4
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Birth; Yes
DT 6 years; Yes
DTwP 18 months; Yes
DTwPHibHep 2, 4, 6 months; Yes
HepB birth; Yes
Hib 18 months; Yes
Influenza >= 65 years; Yes and risk groups
MenBC 3, 5 months; Yes
MMR 12 months; 6 years; Yes
OPV <1, 1, 2, 9 years; Yes
TT 15 years; Yes
Typhoid 10, 13, 16 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2011-2012  2010-2015  2011-2015  2005-2010  2005-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 168  168 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 168  168  168  169  169  169  169 
Nº districts with DTP3 coverage >=80% number 162  168  168  143  154  166  37 
% of districts with DTP3 coverage >=80% From 0 to 100% 96  100  100  85  91  98  22 
Nº districts with measles (MCV1) coverage >=95% number 154  152  154  130  141  157   
% of districts with MCV1 coverage >=95% From 0 to 100% 92  90  92  77  83  93   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 99  99  99  99  99  99  99 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.